Research programme: breast cancer therapeutics - imMAGE BiotherapeuticsAlternative Names: DNA based Vaccine/Anti-CTL4 - Immage Biotehrapeutics; DNA based Vaccine/Anti-PD-L1 - Immage Biotehrapeutics
Latest Information Update: 01 Dec 2016
At a glance
- Originator Immage Biotherapeutics
- Class Antineoplastics; Cancer vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Breast cancer